Sinophare Biotechnology
Human Medicines
Expert R&D, Reliable Custom Products
We supply a full line of GMP/USP/BP standard insulin and GLP‑1 receptor agonists for type 1 & type 2 diabetes. Insulin provides basal/prandial glycemic control; GLP‑1 offers glucose‑dependent insulin secretion, appetite suppression and weight management. All products with complete COA/DMF/registration dossiers for global markets.
